MARÍA LUISA
ZAMARRO ARRANZ
Profesora asociada
Publicaciones (12) Publicaciones de MARÍA LUISA ZAMARRO ARRANZ
2020
-
Perspectives of victims of gender violence
Journal of Psychosocial Nursing and Mental Health Services, Vol. 58, Núm. 6, pp. 30-39
2011
-
Un procedimiento breve y rápido para medir la intensidad de los síntomas depresivos en atención primaria
Actas Espanolas de Psiquiatria, Vol. 39, Núm. 1, pp. 45-48
2010
-
Factors triggering medical consultation for symptoms of colorectal cancer and perceptions surrounding diagnosis
European Journal of Cancer Care, Vol. 19, Núm. 2, pp. 192-199
2009
-
Symptoms that contribute to the perception of depressive sympton intensity. A preliminary study
Actas Espanolas de Psiquiatria, Vol. 37, Núm. 4, pp. 191-195
-
The axial diagnostic criteria for depression. development, construct and predictive validity and reliability
Actas Espanolas de Psiquiatria, Vol. 37, Núm. 6, pp. 306-319
2005
-
Enfermedad celíaca: Propuesta para diagnóstico en atención primaria
Pediatrika, Vol. 25, Núm. 7, pp. 9-14
-
Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients
European Journal of Clinical Nutrition, Vol. 59, Núm. 1, pp. 145-147
-
Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2
Journal of Diabetes and its Complications, Vol. 19, Núm. 1, pp. 42-46
2003
-
Effect of c-reactive protein and interleukins blood levels in postsurgery arginine-enhanced enteral nutrition in head and neck cancer patients
European Journal of Clinical Nutrition, Vol. 57, Núm. 1, pp. 96-99
-
Relation between total homocysteine levels and beer intake in patients with diabetes mellitus type 2
Annals of Nutrition and Metabolism, Vol. 47, Núm. 3-4, pp. 119-123
2002
-
Total homocysteine and cognitive deterioration in people with type 2 diabetes
Diabetes Research and Clinical Practice, Vol. 55, Núm. 3, pp. 185-190
2001
-
Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: A randomized prospective trial
European Journal of Clinical Nutrition, Vol. 55, Núm. 12, pp. 1048-1052